Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G N Fuller

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Journal of Computer Assisted Tomography|November 1, 1989
Intracerebral extension of nasal dermoid cyst: CT appearanceJ P Uglietta, O B Boyko, D J Rippe, et al.
AJNR. American Journal of Neuroradiology|July 1, 1990
Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor disseminationD J Rippe, O B Boyko, G N Fuller, et al.
Postgraduate Medical Journal|December 1, 1988
Nature, incidence and prognosis of neurological involvement in the acquired immunodeficiency syndrome in central LondonR J Guiloff, G N Fuller, A Roberts, et al.
The Journal of Pediatrics|October 1, 1992
Back pain and paraplegia in a fifteen-year-old boyR K Malik, G N Fuller, W J Oakes, et al.
Bone Marrow Transplantation|January 9, 1998
Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2D Przepiorka, K A Jaeckle, R R Birdwell, et al.
Journal of Neuropathology and Experimental Neurology|November 1, 1991
Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivoC J Wikstrand, X M He, G N Fuller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomasC N Rao, S S Lakka, Y Kin, et al.
Oncology Reports|February 19, 1999
Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profilingC H Rhee, S Ruan, S Chen, et al.
Neurosurgery|January 23, 1999
Sacral chordoma: 40-year experience at a major cancer centerJ E York, A Kaczaraj, D Abi-Said, et al.
Oncogene|May 29, 1999
cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell linesC H Rhee, K Hess, J Jabbur, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Journal of Computer Assisted Tomography|November 1, 1989
Intracerebral extension of nasal dermoid cyst: CT appearanceJ P Uglietta, O B Boyko, D J Rippe, et al.
AJNR. American Journal of Neuroradiology|July 1, 1990
Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor disseminationD J Rippe, O B Boyko, G N Fuller, et al.
Postgraduate Medical Journal|December 1, 1988
Nature, incidence and prognosis of neurological involvement in the acquired immunodeficiency syndrome in central LondonR J Guiloff, G N Fuller, A Roberts, et al.
The Journal of Pediatrics|October 1, 1992
Back pain and paraplegia in a fifteen-year-old boyR K Malik, G N Fuller, W J Oakes, et al.
Bone Marrow Transplantation|January 9, 1998
Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2D Przepiorka, K A Jaeckle, R R Birdwell, et al.
Journal of Neuropathology and Experimental Neurology|November 1, 1991
Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivoC J Wikstrand, X M He, G N Fuller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomasC N Rao, S S Lakka, Y Kin, et al.
Oncology Reports|February 19, 1999
Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profilingC H Rhee, S Ruan, S Chen, et al.
Neurosurgery|January 23, 1999
Sacral chordoma: 40-year experience at a major cancer centerJ E York, A Kaczaraj, D Abi-Said, et al.
Oncogene|May 29, 1999
cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell linesC H Rhee, K Hess, J Jabbur, et al.
Pageof 16